Zhuang Liu Selected Research

manganese dioxide

11/2021	Multifunctional MnO2 nanoparticles for tumor microenvironment modulation and cancer therapy.
10/2017	Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses.
1/2017	Albumin-Templated Manganese Dioxide Nanoparticles for Enhanced Radioisotope Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhuang Liu Research Topics

Disease

284	Neoplasms (Cancer) 07/2022 - 12/2004
37	Hypoxia (Hypoxemia) 02/2022 - 10/2015
28	Neoplasm Metastasis (Metastasis) 06/2022 - 08/2014
19	Breast Neoplasms (Breast Cancer) 04/2022 - 02/2008
9	Hyperthermia 03/2022 - 10/2017
8	Inflammation (Inflammations) 01/2022 - 01/2017
6	Infections 01/2022 - 03/2002
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2019
5	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2018
4	Wounds and Injuries (Trauma) 10/2022 - 11/2014
4	Glioma (Gliomas) 01/2022 - 12/2014
3	Necrosis 01/2022 - 12/2021
3	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

45	Pharmaceutical PreparationsIBA 01/2022 - 08/2007
29	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 09/2011
26	Oxygen (Dioxygen)IBA 01/2021 - 07/2015
24	PolymersIBA 01/2022 - 05/2011
22	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2017
18	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
18	Therapeutic UsesIBA 12/2021 - 11/2013
17	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 09/2011
14	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 08/2016
14	AlbuminsIBA 01/2022 - 11/2014
14	Radioisotopes (Radionuclides)IBA 01/2021 - 10/2015
12	HydrogelsIBA 07/2022 - 08/2015
12	Biological ProductsIBA 06/2022 - 08/2008
12	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2007
12	GraphiteIBA 01/2017 - 08/2008
11	AntigensIBA 01/2022 - 05/2014
11	LigandsIBA 01/2022 - 10/2008
11	Coloring Agents (Dyes)IBA 11/2020 - 12/2011
11	Carbon Nanotubes (Carbon Nanotube)IBA 01/2016 - 08/2008
10	CytokinesIBA 01/2022 - 07/2015
10	phytochlorinIBA 01/2022 - 09/2011
10	ProdrugsIBA 11/2020 - 08/2008
10	Liposomes (Liposome)IBA 10/2020 - 01/2017
9	Contrast MediaIBA 03/2022 - 06/2010
9	VaccinesIBA 01/2022 - 06/2015
9	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 03/2012
9	EnzymesIBA 01/2022 - 01/2017
9	MetalsIBA 10/2021 - 03/2014
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2002
8	IronIBA 01/2022 - 04/2015
8	Peptides (Polypeptides)IBA 01/2022 - 08/2002
8	Cancer VaccinesIBA 11/2021 - 01/2018
7	LipidsIBA 05/2022 - 10/2017
7	CatalaseIBA 01/2022 - 09/2017
7	NanovaccinesIBA 01/2022 - 01/2018
7	OxidesIBA 01/2021 - 08/2008
7	Chelating AgentsIBA 11/2018 - 05/2015
7	graphene oxideIBA 10/2016 - 03/2012
6	MXeneIBA 03/2022 - 12/2017
6	Glutathione (Reduced Glutathione)IBA 01/2022 - 01/2019
6	AntibodiesIBA 01/2022 - 02/2008
6	Biocompatible Materials (Biomaterials)IBA 01/2022 - 10/2018
6	ChitosanIBA 01/2022 - 01/2016
6	Singlet OxygenIBA 01/2020 - 09/2011
6	ferric oxide (iron oxide)IBA 01/2018 - 08/2013
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2002
5	PlatinumIBA 01/2022 - 08/2008
5	Folic Acid (Vitamin M)FDA LinkGeneric 06/2021 - 08/2008
5	FluorocarbonsIBA 07/2020 - 04/2016
5	Human Serum Albumin FDA LinkGeneric 06/2019 - 09/2015
5	Drug CarriersIBA 05/2018 - 08/2013
4	InterferonsIBA 07/2022 - 01/2011
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 06/2019
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2011
4	polydopamineIBA 06/2021 - 01/2016
4	Ethylene Glycol (Monoethylene Glycol)IBA 03/2021 - 08/2007
4	tetracarboxyphenylporphineIBA 01/2021 - 08/2016
4	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2014
4	SolutionsIBA 01/2021 - 12/2017
4	IonsIBA 11/2020 - 11/2015
4	MicellesIBA 10/2020 - 07/2013
4	Hydroxyl RadicalIBA 10/2020 - 10/2019
4	Monoclonal AntibodiesIBA 01/2019 - 03/2012
4	arginyl-glycyl-aspartic acidIBA 05/2015 - 10/2008
4	IntegrinsIBA 12/2014 - 06/2010
3	oxidized low density lipoproteinIBA 01/2022 - 01/2021
3	titanium carbideIBA 01/2022 - 11/2016
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022 - 01/2020
3	KynurenineIBA 01/2022 - 10/2020
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 01/2021
3	flopropioneIBA 01/2022 - 05/2018
3	AntioxidantsIBA 01/2022 - 07/2015

Therapy/Procedure

147	Therapeutics 10/2022 - 08/2008
67	Precision Medicine 01/2022 - 10/2011
52	Photothermal Therapy 02/2022 - 09/2010
42	Intravenous Injections 01/2022 - 03/2012
41	Immunotherapy 07/2022 - 06/2015
41	Radiotherapy 01/2022 - 10/2015
40	Drug Therapy (Chemotherapy) 01/2022 - 10/2013
34	Photochemotherapy (Photodynamic Therapy) 01/2022 - 09/2011
25	Lasers (Laser) 01/2021 - 09/2010
5	Intravesical Administration 01/2022 - 01/2019
5	Intravenous Administration 03/2021 - 06/2010
5	Phototherapy (Light Therapy) 04/2020 - 11/2014
4	Hemoperfusion 01/2022 - 12/2021
3	Microspheres (Microsphere) 01/2022 - 10/2021